O-107 FISH and Immunohistochemistry (IHC) can be used to selectNSCLC patients, who will not benefit from gefitinib treatment

F. Hirsch, J. McCoy, F. Cappuzzo, W. Howard Jack, P. Gumerlock, L. Crino, W. Franklin, D. Gandara, M. Varella-Garcia, P. Bunn Jr.
  • Lung Cancer, July 2005, Elsevier
  • DOI: 10.1016/s0169-5002(05)80241-7

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Dr Federico Cappuzzo